Indoco Remedies — 360° view

Indoco Remedies, a company in the Pharmaceuticals industry, reported revenue of ₹520 crore and net profit of ₹19 crore for the September 2026 quarter.

Indoco Remedies (NSE: INDOCO) closed at ₹232.15 on 20 Nov 2026, down 7.9% over the past year. Its market capitalisation is ₹2,143 crore.

Share price
₹232.15 (20 Nov 2026)
Market cap
₹2,143 Cr (20 Nov 2026)
Revenue
₹520 Cr (September 2026 quarter)
Net profit
₹19 Cr (September 2026 quarter)
ROCE
0.96% (FY26)
ROE
-9.36% (FY26)
Book value
₹111 (FY26)
Dividend yield
0.09% (last 12 months to 20 Nov 2026)
52-week high / low
₹287.80 / ₹162.19 (20 Nov 2026)
1-year return
-7.9% (to 20 Nov 2026)
Sector
Healthcare
Industry
Pharmaceuticals
Symbol
NSE: INDOCO

Indoco Remedies (Indoco) is a Mumbai-based pharmaceutical company that focuses on formulations with a presence in contract manufacturing and research. The Company is engaged in the manufacturing and marketing of pharmaceutical Formulations (Finished Dosage Forms) and Active Pharmaceutical Ingredients (APIs).

Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.